TY - JOUR
T1 - A narrative review of high-level isolation unit operational and infrastructure features
AU - Lukowski, Joseph
AU - Vasa, Angela
AU - Arguinchona, Christa
AU - Elrayes, Wael
AU - Frank, Maria G.
AU - Galdys, Alison L.
AU - Garcia, Mary C.
AU - Garland, Jennifer A.
AU - Kline, Susan
AU - Persson, Caroline
AU - Ruby, Darrell
AU - Sauer, Lauren M.
AU - Vasistha, Sami
AU - Carrasco, Sharon
AU - Herstein, Jocelyn J.
N1 - Funding Information:
NETEC is funded by the Administration for Strategic Preparedness and Response and Centers for Disease Control and Prevention, (U3REP150549-0549A).
Publisher Copyright:
© 2023 Authors. All rights reserved.
PY - 2023/7/9
Y1 - 2023/7/9
N2 - High-level isolation units (HLIUs) are specially designed facilities for care and management of patients with suspected or confirmed high-consequence infectious diseases (HCIDs), equipped with unique infrastructure and operational features. While individual HLIUs have published on their experiences caring for patients with HCIDs and two previous HLIU consensus efforts have outlined key components of HLIUs, we aimed to summarise the existing literature that describes best practices, challenges and core features of these specialised facilities. A narrative review of the literature was conducted using keywords associated with HLIUs and HCIDs. A total of 100 articles were used throughout the manuscript from the literature search or from alternate methods like reference checks or snowballing. Articles were sorted into categories (eg, physical infrastructure, laboratory, internal transport); for each category, a synthesis of the relevant literature was conducted to describe best practices, experiences and operational features. The review and summary of HLIU experiences, best practices, challenges and components can serve as a resource for units continuing to improve readiness, or for hospitals in early stages of developing their HLIU teams and planning or constructing their units. The COVID-19 pandemic, a global outbreak of mpox, sporadic cases of viral haemorrhagic fevers in Europe and the USA, and recent outbreaks of Lassa fever, Sudan Ebolavirus, and Marburg emphasise the need for an extensive summary of HLIU practices to inform readiness and response.
AB - High-level isolation units (HLIUs) are specially designed facilities for care and management of patients with suspected or confirmed high-consequence infectious diseases (HCIDs), equipped with unique infrastructure and operational features. While individual HLIUs have published on their experiences caring for patients with HCIDs and two previous HLIU consensus efforts have outlined key components of HLIUs, we aimed to summarise the existing literature that describes best practices, challenges and core features of these specialised facilities. A narrative review of the literature was conducted using keywords associated with HLIUs and HCIDs. A total of 100 articles were used throughout the manuscript from the literature search or from alternate methods like reference checks or snowballing. Articles were sorted into categories (eg, physical infrastructure, laboratory, internal transport); for each category, a synthesis of the relevant literature was conducted to describe best practices, experiences and operational features. The review and summary of HLIU experiences, best practices, challenges and components can serve as a resource for units continuing to improve readiness, or for hospitals in early stages of developing their HLIU teams and planning or constructing their units. The COVID-19 pandemic, a global outbreak of mpox, sporadic cases of viral haemorrhagic fevers in Europe and the USA, and recent outbreaks of Lassa fever, Sudan Ebolavirus, and Marburg emphasise the need for an extensive summary of HLIU practices to inform readiness and response.
KW - Control strategies
KW - Environmental health
KW - Health policy
KW - Review
KW - Viral haemorrhagic fevers
UR - http://www.scopus.com/inward/record.url?scp=85165100485&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85165100485&partnerID=8YFLogxK
U2 - 10.1136/bmjgh-2023-012037
DO - 10.1136/bmjgh-2023-012037
M3 - Article
C2 - 37423621
AN - SCOPUS:85165100485
SN - 2059-7908
VL - 8
JO - BMJ Global Health
JF - BMJ Global Health
IS - 7
M1 - e012037
ER -